Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 169 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1681 4.4 months Recurrent GBM 4 Biologic therapy
Chemotherapy
Duke University Medical Center United States 9/2010
Treatment Details: Patients: This study involved a total of 23 glioblastoma multiforme patients who had progressed following previous treatment with bevacizumab. Patients were separated into 2 separate treat
 
1682 4.4 months NSCLC 4 Biologic therapy
Chemotherapy
Service de Pneumologie France 7/2012
Treatment Details: Patients: This phase II study involved 44 elderly advanced non-small-cell lung cancer patients with an average age of 78.2 years; 84.1% were male. Treatment: Patients were treated with
 
1683 4.4 months Malignant mesothelioma 4 Biologic therapy
University of Chicago United States 10/2012
Treatment Details: Patients: This phase II study involved 51 patients with malignant mesothelioma. The median patient age was 64 years and 84% were male. Treatment: Patients were treated with the biologi
 
1684 4.3 months Advanced hepatocellular carcinoma 3 Biologic therapy
Queen Mary Hospital China 3/2012
Treatment Details: Patients: This phase II study involved 10 advanced hepatocellular carcinoma patients who had been previously treated with the biologic therapy agent sorafenib. The median patient age was 4
 
1685 4.3 months Recurrent GBM 5 Biologic therapy
National Cancer Institute, National Institutes of Health United States 1/2013
Treatment Details: Patients: This phase 2 study involved recurrent glioblastoma patients who were divided into two separate patient groups. Group A consisted of 32 patients with a median age of 57 years who
 
1686 4.3 months GBM 4 Biologic therapy
Chemotherapy
Harvard Medical School United States 11/2014
Treatment Details: Patients: This study involved 42 recurrent glioblastoma patients who were previously treated with bevacizumab. The median patient age was 49 years and 66.7% were male. Treatment: Patie
 
1687 4.3 months Advanced NSCLC 3 Chemotherapy
Technische Universität, III. Medizinische Klinik Germany 6/2008
Treatment Details: Patients: This phase II study involved 21 patients with advanced or metastatic non-small cell lung cancer. They had all received treatment for their cancer before entering this study. Ther
 
1688 4.3 months Recurrent GBM Chemotherapy
Hormone
Cleveland Clinic Foundation United States 1/2003
Treatment Details: Patients: This Phase I/II study involved 22 patients with recurrent high-grade gliomas. Fourteen patients had glioblastoma multiforme, four had anaplastic astrocytoma, two had anaplastic ol
 
1689 4.2 months Metastatic or locally advanced NSCLC Radiation
Princess Margaret Hospital/University Health Network Canada 11/2002
Treatment Details: Patients: This Phase III trial study involved 230 patients with metastatic or locally advanced non-small cell lung cancer. Treatment: Patients were divided into two groups – one group (
 
1690 4.1 months Advanced NSCLC 4 Chemotherapy
University of Maryland Greenebaum Cancer Center United States 2/2003
Treatment Details: Patients: This Phase II study involved 25 patients with advanced (stage IIIB or IV) non-small cell lung cancer. All but three patients had received prior chemotherapy. Treatment: The tre
 
Page 169 of 187  | Previous Page  | Next Page